Literature DB >> 28512508

Lhermitte-Duclos Disease and Cerebellar Gangliocytoma-An Incidental Finding in a Patient with Gradual Vision Loss.

Akshay Badakere1, Pratik Chaugule1, Soveeta Souravee Rath1.   

Abstract

A 50-year-old male patient presented to the neuro-ophthalmology clinic with chief complaints of gradual decrease in vision in both eyes, more in the left eye, for 6 years. On general examination, the patient had a hemiplegic gait. His presenting acuity was 20/50 in the right eye and 20/320 in the left eye, not improving further. He had dense posterior subcapsular cataracts in both eyes, and fundus examination revealed pale discs. Humphrey visual field tests 30-2 revealed a vertical nasal midline defect in the right eye and grossly depressed fields in the left eye. Keeping in mind the above findings, the authors requested for a magnetic resonance imaging (MRI) of the brain. The brain MRI shows a large infarct in the right parieto-occipital lobe and a small circumscribed lesion in the left cerebellum. The radiologist opined that it could possibly be a gangliocytoma of the cerebellum, and a possible diagnosis of Lhermitte-Duclos syndrome was made.

Entities:  

Keywords:  Lhermitte-Duclos disease; cerebellar gangliocytoma

Year:  2017        PMID: 28512508      PMCID: PMC5417168          DOI: 10.1080/01658107.2017.1291685

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  3 in total

1.  Lhermitte-Duclos disease and Cowden's syndrome. Report of two cases.

Authors:  J Peltier; C Lok; A Fichten; A Bruniau; M Lefranc; P Toussaint; C Desenclos; D Le Gars
Journal:  Neurochirurgie       Date:  2006-11       Impact factor: 1.553

Review 2.  Lhermitte-Duclos disease (dysplastic cerebellar gangliocytoma): a malformation, hamartoma or neoplasm?

Authors:  D A Nowak; H A Trost
Journal:  Acta Neurol Scand       Date:  2002-03       Impact factor: 3.209

3.  An unusual cause of posterior fossa mass: Lhermitte-Duclos disease.

Authors:  Begül Yağci-Küpeli; Kader K Oguz; M Asim Bilen; Bilgehan Yalçin; Nejat Akalan; Münevver Büyükpamukçu
Journal:  J Neurol Sci       Date:  2010-01-08       Impact factor: 3.181

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.